POINT BIOPHARMA GLOBAL INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-07-07: Reporting owner Hammond Matthew; Form 3; Security Class B Common Stock; Transaction Holding.
- 2020-07-07: Reporting owner Therapeutics Acquisition Holdings LLC; Form 3; Security Class B Common Stock; Transaction Holding.
- 2020-07-07: Reporting owner GRAY MICHAEL; Form 3; Security Class B Common Stock; Transaction Holding.
- 2020-07-07: Reporting owner Grau Daniel; Form 3; Security Class B Common Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-07-07 holding as of filing | Hammond Matthew Director, Officer (Chief Financial Officer) | 3 | Class B Common Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2020-07-07 | ||
| 2020-07-07 holding as of filing | Therapeutics Acquisition Holdings LLC 10% Owner | 3 | Class B Common Stock Derivative · Direct | Holding | no price filed | 2020-07-07 | ||
| 2020-07-07 holding as of filing | GRAY MICHAEL Director | 3 | Class B Common Stock Derivative · Direct | Holding | no price filed | 2020-07-07 | ||
| 2020-07-07 holding as of filing | Grau Daniel Director | 3 | Class B Common Stock Derivative · Direct | Holding | no price filed | 2020-07-07 | ||
| 2020-07-07 holding as of filing | Lubner David Charles Director | 3 | Class B Common Stock Derivative · Direct | Holding | no price filed | 2020-07-07 |